LFMD

MKT CAP:$221M

LifeMD, Inc.

Market Cap

$221M

Healthcare·Medical - Pharmaceuticals·🇺🇸 United States·NASDAQ

Healthcare·Medical·🇺🇸·NASDAQ

Stock Price

$4.95+$1.46 (+41.83%)

Apr 21, 2026

Company Details

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United St...

CEO

Justin Schreiber

IPO Date

Jan 29, 2008

Website

www.lifemd.com

Key Metrics TTM

Revenue

$112M

+615.4% YoY

Net Income

-$59M

EPS (Diluted)

-$2.08

Free Cash Flow

-$33M

Revenue / Share

$3.63

Gross Margin

81.6%

Operating Margin

-46.7%

Net Margin

-52.5%

FCF Margin

-29.3%

P/S

2.0x

P/E

—

Earnings Reports

Q3 2022

May 5, 2026

PENDING

FY 2023

Mar 11, 2024

$153MEPS -$0.70

Q2 2022

Aug 11, 2022

$30MEPS -$0.42

Q1 2022

May 13, 2022

$29MEPS -$0.44

Q4 2021

Mar 7, 2022

$27MEPS -$0.68

Revenue & Profitability

Quarter	Revenue	Gross Profit	Operating Income
Q1 17	$424.5K	$221.1K	-$375.0K
Q2 17	$1M	$778.2K	-$225.5K
Q3 17	$2M	$2M	-$273.6K
Q4 17	$1M	$1M	-$193.5K
Q3 20	$11M	$9M	-$21M
Q3 21	$25M	$20M	-$13M
Q4 21	$27M	$22M	-$14M
Q1 22	$29M	$24M	-$13M
Q2 22	$30M	$26M	-$13M

Valuation

Quarter	P/S	P/E
Q1 17	—	—
Q2 17	—	—
Q3 17	—	—
Q4 17	2.9x	—
Q3 20	7.2x	—
Q3 21	4.6x	—
Q4 21	1.9x	—
Q1 22	1.1x	—
Q2 22	0.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 17	-$473.3K	-$473.3K
Q2 17	-$39.3K	-$39.3K
Q3 17	$196.9K	$196.9K
Q4 17	-$501.5K	-$501.5K
Q3 20	-$4M	-$4M
Q3 21	-$7M	-$8M
Q4 21	-$6M	-$6M
Q1 22	-$8M	-$8M
Q2 22	-$10M	-$10M

Capital Expenditures

Quarter	CapEx
Q1 17	$0
Q2 17	$0
Q3 17	$0
Q4 17	$0
Q3 20	$1
Q3 21	$853.4K
Q4 21	$177.3K
Q1 22	$267.1K
Q2 22	$90.2K

CapEx

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q3 20	+2492.9%	+3845.0%
Q3 21	+2152.7%	+2716.3%
Q4 21	+1236.3%	+1666.7%
Q1 22	+1874.2%	+2432.1%
Q2 22	+176.8%	+37.5%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 17	$190.2K	44.8%
Q2 17	-$76.7K	-6.9%
Q3 17	$49.2K	2.4%
Q4 17	$340.0K	23.1%
Q3 20	$0	0.0%
Q3 21	$3M	12.5%
Q4 21	$0	0.0%
Q1 22	$0	0.0%
Q2 22	$0	0.0%

OpEx Breakdown

Quarter	R&D	G&A	S&M
Q1 17	—	$585.3K	$10.8K
Q2 17	—	$714.6K	$289.1K
Q3 17	—	$906.9K	$882.8K
Q4 17	—	$774.6K	$474.4K
Q3 20	$118.3K	$18M	$11M
Q3 21	$128.1K	$11M	$20M
Q4 21	$343.4K	$11M	$21M
Q1 22	$428.3K	$12M	$22M
Q2 22	$701.1K	$13M	$22M

Revenue Segments

Quarter	Telehealth Revenue Net	Work Simpli Revenue Net
Q1 22	$23M	$6M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 22	$25M	$0	$25M
Q2 22	$12M	$0	$12M
Q3 22	$6M	$0	$6M
Q4 22	$4M	$0	$4M
Q1 23	$12M	$0	$12M
Q2 23	$12M	$0	$12M
Q3 23	$15M	$0	$15M
Q4 23	$33M	$0	$33M
Q1 24	$35M	$0	$35M
Q2 24	$36M	$0	$36M
Q3 24	$38M	$0	$38M
Q4 24	$35M	$0	$35M
Q1 25	$34M	$0	$34M
Q2 25	$36M	$0	$36M
Q3 25	$24M	$0	$24M
Q4 25	$37M	$0	$37M

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change	YoY Change
Q1 17	8M	—	—
Q2 17	8M	+1.1%	—
Q3 17	9M	+7.6%	—
Q4 17	9M	-0.5%	—
Q3 20	16M	+78.5%	+93.2%
Q3 21	27M	+71.8%	+228.2%
Q4 21	27M	0.0%	+205.0%
Q1 22	31M	+15.6%	+254.6%
Q2 22	31M	-0.2%	+98.3%

Shares Outstanding

Revenue Per Employee

Period	Revenue/Employee	Employees
Q1 17	$38.6K	11
Q2 17	$100.7K	11
Q3 17	$186.5K	11
Q4 17	$133.7K	11
Q3 20	$423.3K	26
Q3 21	$445.5K	56
Q4 21	$118.2K	232
Q1 22	$125.2K	232
Q2 22	$131.3K	232

Revenue / Employee